AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
46 hedge funds and large institutions have $8.33M invested in Accelerate Diagnostics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
46
Holding in Top 10
–
Calls
$34K
Puts
$1K
Top Buyers
| 1 | +$843K | |
| 2 | +$270K | |
| 3 | +$130K | |
| 4 |
Renaissance Technologies
New York
|
+$70.2K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$34K |
Top Sellers
| 1 | -$231K | |
| 2 | -$15.7K | |
| 3 | -$13.3K | |
| 4 |
VF
Virtu Financial
New York
|
-$12K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.18K |